Sara O. Dionne, Ph.D. - Publications

Affiliations: 
2002 University of Arizona, Tucson, AZ 
Area:
Immunology

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Myers CE, Dionne SO, Shakalya K, Mahadevan D, Smith MH, Lake DF. Variation in cytotoxic T-lymphocyte responses to peptides derived from tyrosinase-related protein-2. Human Immunology. 69: 24-31. PMID 18295672 DOI: 10.1016/j.humimm.2007.11.010  0.56
2006 Dionne SO, Podany AB, Ruiz YW, Ampel NM, Galgiani JN, Lake DF. Spherules derived from Coccidioides posadasii promote human dendritic cell maturation and activation. Infection and Immunity. 74: 2415-22. PMID 16552071 DOI: 10.1128/IAI.74.4.2415-2422.2006  0.56
2005 Ampel NM, Nelson DK, Li L, Dionne SO, Lake DF, Simmons KA, Pappagianis D. The mannose receptor mediates the cellular immune response in human coccidioidomycosis. Infection and Immunity. 73: 2554-5. PMID 15784604 DOI: 10.1128/IAI.73.4.2554-2555.2005  0.56
2004 Dionne SO, Lake DF, Grimes WJ, Smith MH. Identification of HLA-Cw6.02 and HLA-Cw7.01 allele-specific binding motifs by screening synthetic peptide libraries. Immunogenetics. 56: 391-8. PMID 15309347 DOI: 10.1007/s00251-004-0710-1  0.56
2004 Dionne SO, Myers CE, Smith MH, Lake DF. Her-2/ neu altered peptide ligand-induced CTL responses: implications for peptides with increased HLA affinity and T-cell-receptor interaction. Cancer Immunology, Immunotherapy : Cii. 53: 307-14. PMID 14605764 DOI: 10.1007/s00262-003-0439-y  0.56
2003 Dionne SO, Smith MH, Marincola FM, Lake DF. Functional characterization of CTL against gp100 altered peptide ligands. Cancer Immunology, Immunotherapy : Cii. 52: 199-206. PMID 12669244 DOI: 10.1007/s00262-002-0358-3  0.56
2001 Dionne SO, Smith MH, Marincola FM, Lake DF. Antigen presentation of a modified tumor-derived peptide by tumor infiltrating lymphocytes. Cellular Immunology. 214: 139-44. PMID 12088412 DOI: 10.1006/cimm.2001.1893  0.56
Show low-probability matches.